Hereditary Spastic Paraplegia Type 5
📧 Sign up to get email alerts when something new happens for Hereditary Spastic Paraplegia Type 5.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: PCSK9 Inhibitor Treatment for Patients With SPG5 [Phase 1, Phase 2]
Clinical trial update for a PCSK9 inhibitor in patients with Hereditary Spastic Paraplegia Type 5 (Phase 1/2).